Genable is a specialty biotech company spun out of Trinity College Dublin with significant backing from venture capital investors and a management team with a proven track record of achievements.
Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2
Telephone:+353 (0)1 608 3390
Fax:+353 (0)1 608 3848
Dr Gearoid Tuohy
Genable is commercializing a suite of gene based technologies with the potential to treat more than 100 presently incurable genetic disorders.
The Company's current market focus is on two orphan indications - retinitis pigmentosa and osteogenesis imperfecta.
Genable's underlying platform technology may be applied to a broad range of 'dominant' genetic diseases and is currently being made available for licensing to select industry partners.
Genable controls a broad suite of granted patents and patent applications in the USA, EU and worldwide which open entirely new markets previously ignored due to a lack of appropriate technology. Genable now presents the opportunity to tap this multi-billion euro markets characterised by significant unmet clinical need.